Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis.
Giuseppe BronteVincenza ConteducaMatteo LandriscinaAntonio Domenico ProcopioPublished in: Prostate cancer and prostatic diseases (2022)
High levels of circulating MDSCs induce a worse OS in prostate cancer patients than in those with low levels. This finding supports the importance of MDSC detection and targeting also in prostate cancer patients.
Keyphrases
- prostate cancer
- end stage renal disease
- radical prostatectomy
- induced apoptosis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- benign prostatic hyperplasia
- cell cycle arrest
- oxidative stress
- patient reported outcomes
- signaling pathway
- cell proliferation
- endoplasmic reticulum stress
- drug delivery
- sensitive detection
- loop mediated isothermal amplification
- free survival